期刊文献+

基于机体反馈调控保护 扭转肿瘤治疗思路 被引量:3

Change the Way of Thinking about Cure Tumor Based on the Protection of Organism's Feedback Adjustment
下载PDF
导出
摘要 肿瘤的临床治疗经过漫长积极探索研究,中西医疗效均未取得成就性突破,本文穿越时空隧道,基于人类亿万年适应环境生存生物进化历程形成的精细反馈调控保护视角,循证机体实施反馈调控保护顽强延续生命依据,结合肿瘤病理生理机制,剖析肿瘤形成原因,追溯肿瘤临床治疗误区,扭转肿瘤治疗思路,引领肿瘤治疗新路径。 Ahhough the clinical treatment of tumor has been explored and researched for a long time. The curative effect of both Traditional Chinese and Western medicine has never made a successful breakthrough. This article is based on the pro- tection of organism's feedback adjustment combining pathologic and physiology mechanism of curing tumor, analyses the causes of tumor, which has changed the traditional thinking of curing tumor , has explored a new approach of treatment of tumor.
作者 马原野
出处 《医学与哲学(B)》 2011年第3期18-19,共2页 Medicine & Philosophy(B)
关键词 肿瘤 病机 反馈调节 治疗 tumor, pathologic mechanism, feedback adjusting, treatment
  • 相关文献

参考文献4

  • 1谈家桢,潘重光.生命与克隆杂谈[M].上海:上海教育出版社,2005:79-80.
  • 2肖纯凌,赵富玺.病毒生物学和免疫学[M].6版.北京:人民卫生出版社,2010:372.
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 4华芳.病毒与肿瘤关系的研究进展.长春医学,2005,.

共引文献273

同被引文献22

  • 1徐晓艳,周向东.中性粒细胞弹性蛋白酶与黏蛋白[J].中国药物与临床,2004,4(10):741-744. 被引量:11
  • 2华芳.病毒与肿瘤关系的研究进展.长春医学,2005,.
  • 3Sakaguchi S, Sakaguchi N, Asano M, et al . Immunological selft olerance maintained by activated T cells expressing IL -- 2 receptors2 chains (CD2s) . Breakdown of single mechanism of self -tolerance causes various autoimmune disease[J]. J Immunol, 1995,155(3) : 1151- 1164 .
  • 4Khazaie K, Von Boehmer H. The impact of CD4+CD25+Treg on tumor specific CD8+ T cell cytotoxicity and cancer[J]. Semin Cancer Biol, 2006,16(2) :124-136.
  • 5Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 programs thedevelopment and function of CD4 + CD25 + regulatory Tcells[J]. Nat Immunol,2003,4(4) :330-336.
  • 6Dunn G P, Bruce A T, Ikeda H, et al. Cancer immunoediting= From immunosurveillanee to tumor escape [ J ]. Nat Immunol, 2002, 3(11): 991-998.
  • 7Curtin J F, Candolfi M, Fakhouri T M,et al. Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials[J].PLoSONE,2008,3(4):1983.
  • 8Menard C, Ghiringhelli F, Roux S,et al. Ctla 4 blockade confers lymphocyte resistance to regulatory T--cells in advanced melanoma: surrogate marker of efficacy of tremelimumab[J]. Clin Cancer Res, 2008,14 (16) : 5242- 5249.
  • 9Ramirez-- Montagut T, Chow A, Hirschhorn-- Cymerman D, et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ ignorance to melanoma differentiation antigens and enhances antitumor immunity[J]. J Immunol, 2006,176(11):6434-6442.
  • 10Zhou P, Zheng X, Zhang H, et al. B7 blockade alters the balance between regulatory T cells and tumor--reactive T cells for immunotherapy of cancer[J]. Clin Cancer Res,2009,15(3) :960--970.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部